Femara and alanine aminotransferase increased 
Femara and alanine aminotransferase increased Patient Reports February 10, 2012
Femara Side Effects Report #6028979-5
Femara side effect was reported by a Health Professional from FRANCE on Dec 30, 2008. Female patient, weighting 134.5 lb, was diagnosed with neoplasm malignant, tachycardia, hypercholesterolaemia and was treated with Femara. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood amylase increased, blood bilirubin increased, diarrhoea. Femara dosage: 2.5 MG, QD. During the same period patient was treated with BISOPROLOL FUMARATE, PRAVASTATIN. Patient recovered.
Femara Side Effects Report #4984164-7
Femara side effect was reported by a Physician from COLOMBIA on Mar 31, 2006. Female patient, 57 years of age, was diagnosed with breast cancer stage iv and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, arthralgia, aspartate aminotransferase increased, blood alkaline phosphatase increased, bone pain, constipation
, diarrhoea, gastric cancer. Femara dosage: 2.5 MG/DAY. Patient recovered.Femara Side Effects Report #4997798-0
Femara side effect was reported by a Physician from COLOMBIA on Mar 31, 2006. Female patient, 57 years of age, was diagnosed with breast cancer stage iv and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, arthralgia, aspartate aminotransferase increased, blood alkaline phosphatase increased, bone pain, constipation
, diarrhoea, gastric cancer. Femara dosage: 2.5 MG/DAY. Patient recovered.Femara Side Effects Report #4977523-X
Femara side effect was reported by a Physician from COLOMBIA on Mar 31, 2006. Female patient, 57 years of age, was diagnosed with breast cancer female and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, blood alkaline phosphatase increased, bulimia nervosa, gastric cancer, weight decreased. Femara dosage: 2.5 MG/DAY. Patient recovered.
Femara Side Effects Report #5165392-7
Femara side effect was reported by a Physician from SOUTH AFRICA on Nov 08, 2006. Female patient, 40 years of age, was diagnosed with breast cancer female and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood electrolytes abnormal, blood immunoglobulin e increased, blood lactate dehydrogenase increased, blood ph increased, blood pressure diastolic increased, blood urea abnormal. Femara dosage: unknown. During the same period patient was treated with ANTIASTHMATICS, ACE INHIBITOR NOS, ATACAND. Patient was hospitalized. Patient recovered.
Femara Side Effects Report #5267003-9
Femara side effect was reported by a Physician from UNITED KINGDOM on Mar 06, 2007. Female patient, 84 years of age, weighting 185.0 lb, was diagnosed with breast cancer
, left ventricular failure, reflux gastritis, angina pectoris, constipation and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood urea increased, bone density decreased, c-reactive protein increased, gamma-glutamyltransferase increased, glomerular filtration rate decreased, liver function test abnormal, lumbar spine flattening. Femara dosage: 2.5MG / DAY. During the same period patient was treated with FRUSEMIDE, OMEPRAZOLE, ISOSORBIDE MONONITRATE, AMLODIPINE, LACTULOSE, SALBUTAMOL. Patient recovered.Femara Side Effects Report #5278505-3
Femara side effect was reported by a Physician from UNITED KINGDOM on Mar 16, 2007. Female patient, 84 years of age, weighting 185.0 lb, was diagnosed with breast cancer
, left ventricular failure, reflux gastritis, angina pectoris, constipation and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood urea increased, bone density decreased, c-reactive protein increased, gamma-glutamyltransferase increased, glomerular filtration rate decreased, liver function test abnormal, lumbar spine flattening. Femara dosage: 2.5MG / DAY. During the same period patient was treated with FRUSEMIDE, OMEPRAZOLE, ISOSORBIDE MONONITRATE, AMLODIPINE, LACTULOSE, SALBUTAMOL. Patient recovered.Femara Side Effects Report #5782445-0
Femara side effect was reported by a Physician from FRANCE on June 09, 2008. Female patient, 72 years of age, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, gamma-glutamyltransferase increased. Femara dosage: 2.5 MG/DAY. During the same period patient was treated with VISKEN, MIANSERIN, CLOMIPRAMINE, LORAZEPAM, ZOPICLONE, OGAST. Patient recovered.Femara Side Effects Report #5476871-7
Femara side effect was reported by a Health Professional from JAPAN on Sept 28, 2007. Female patient, 67 years of age, weighting 134.5 lb, was diagnosed with breast cancer
and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, haematocrit decreased, haemoglobin decreased, metastases to bone marrow, pancytopenia, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Femara dosage: 2.5 MG/D. During the same period patient was treated with TAXOTERE, MAGMITT KENEI, FLOMOX, LANIRAPID. Patient was hospitalized. Patient recovered.Femara Side Effects Report #5361548-9
Femara side effect was reported by a Physician from GERMANY on June 06, 2007. Female patient, 64 years of age, weighting 238.1 lb, was diagnosed with breast cancer
and was treated with Femara. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cytomegalovirus infection , cytomegalovirus test positive, dehydration, endoscopy upper gastrointestinal tract abnormal, epstein-barr virus antibody positive. Femara dosage: 2.5 MG. During the same period patient was treated with FUROSEMIDE, DECORTIN, DOXEPIN, ACETYLSALICYLIC ACID SRT, THEOPHYLLINE, EFEROX, MORPHINE, FLUPIRTINE MALEATE. Patient was hospitalized. Patient recovered.Femara Side Effects Report #5378888-X
Femara side effect was reported by a Physician from GERMANY on June 27, 2007. Female patient, 64 years of age, weighting 238.1 lb, was diagnosed with breast cancer
and was treated with Femara. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cytomegalovirus infection , cytomegalovirus test positive, dehydration, endoscopy upper gastrointestinal tract abnormal, epstein-barr virus antibody positive. Femara dosage: 2.5 MG. During the same period patient was treated with FUROSEMIDE, DECORTIN, DOXEPIN, ASPIRIN, THEOPHYLLINE, EFEROX, MORPHINE, FLUPIRTINE MALEATE. Patient was hospitalized. Patient recovered.Femara Side Effects Report #5430310-0
Femara side effect was reported by a Physician from on Aug 27, 2007. Female patient, 64 years of age, weighting 134.5 lb, was diagnosed with breast cancer
and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cholelithiasis, gamma-glutamyltransferase increased, glioblastoma, transaminases increased. Femara dosage: unknown. Patient recovered.Femara Side Effects Report #5224914-8
Femara side effect was reported by a Physician from JAPAN on Jan 10, 2007. Female patient, 46 years of age, weighting 83.78 lb, was diagnosed with breast cancer
and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, malignant neoplasm progression, metastases to bone, metastases to liver, metastases to lung, oral intake reduced. Femara dosage: 2.5 MG, QD. During the same period patient was treated with DUROTEP JANSSEN, LOXONIN, MARZULENE S, NAPROXEN, NAVELBINE, ARIMIDEX. Patient died on 10/09/2006.Femara Side Effects Report #5468202-3
Femara side effect was reported by a Health Professional from JAPAN on Sept 20, 2007. Female patient, weighting 134.5 lb, was diagnosed with breast cancer
and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, haematocrit decreased, haemoglobin decreased, metastases to bone marrow, pancytopenia, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Femara dosage: 2.5 MG/D. During the same period patient was treated with TAXOTERE, MAGMITT KENEI, FLOMOX, LANIRAPID. Patient was hospitalized. Patient recovered.Femara Side Effects Report #5754052-7
Femara side effect was reported by a Physician from JAPAN on May 21, 2008. Female patient, weighting 112.4 lb, was diagnosed with breast cancer
, renal impairment and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, blood urea increased, hepatic failure, jaundice . Femara dosage: 2.5 MG DAILY. During the same period patient was treated with XELODA, LASIX, TETRAMIDE, MYSLEE, LEVOTOMIN, NAPROXEN, OXYCONTIN, PURSENNID. Patient died on 04/06/2007.Femara Side Effects Report #5832753-X
Femara side effect was reported by a Physician from JAPAN on July 31, 2008. Female patient, weighting 119.0 lb, was diagnosed with breast cancer
, insomnia and was treated with Femara. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, appetite disorder, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased. Femara dosage: 2.5 MG, UNK. During the same period patient was treated with EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, MYSLEE, SEROTONE, DEXAMETHASONE PHOSPHATE, PROTECADIN. Patient was hospitalized. Patient died on 05/07/2008.Femara Side Effects Report #5838949-5
Femara side effect was reported by a Physician from UNITED STATES on Aug 05, 2008. Female patient was diagnosed with breast cancer
, neoplasm malignant, neoplasm progression and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation , blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood calcium decreased, blood glucose increased, blood magnesium increased. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ZOMETA, FULVESTRANT, NAVELBINE, HERCEPTIN, ALBUTEROL, ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, OXYGEN. Patient died.Femara Side Effects Report #5840714-X
Femara side effect was reported by a Physician from JAPAN on Aug 06, 2008. Female patient, weighting 119.0 lb, was diagnosed with breast cancer
, insomnia and was treated with Femara. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, appetite disorder, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased. Femara dosage: 2.5 MG, UNK. During the same period patient was treated with EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, MYSLEE, SEROTONE, DEXAMETHASONE PHOSPHATE, PROTECADIN. Patient was hospitalized. Patient died on 05/07/2008.Femara Side Effects Report #5863434-4
Femara side effect was reported by a Physician from JAPAN on Aug 25, 2008. Female patient, weighting 119.0 lb, was diagnosed with breast cancer
, insomnia and was treated with Femara. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, appetite disorder, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased. Femara dosage: 2.5 MG, UNK. During the same period patient was treated with EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, MYSLEE, SEROTONE, DEXAMETHASONE PHOSPHATE, PROTECADIN. Patient was hospitalized. Patient died on 05/07/2008.Femara Side Effects Report #5899568-8
Femara side effect was reported by a Physician from JAPAN on Sept 19, 2008. Female patient was diagnosed with breast cancer
, metastases to bone and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, toxic skin eruption. Femara dosage: 2.5 MG. During the same period patient was treated with ZOMETA. Patient recovered.Femara Side Effects Report #5907269-2
Femara side effect was reported by a Physician from JAPAN on Sept 29, 2008. Female patient, weighting 119.0 lb, was diagnosed with breast cancer
, insomnia and was treated with Femara. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, appetite disorder, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased. Femara dosage: 2.5 MG, UNK. During the same period patient was treated with FARMORUBICIN, CYCLOPHOSPHAMIDE, MYSLEE, SEROTONE, DEXAMETHASONE PHOSPHATE, PROTECADIN. Patient was hospitalized. Patient died on 05/07/2008.Femara Side Effects Report #6087057-X
Femara side effect was reported by a Health Professional from UNITED STATES on Feb 15, 2009. Female patient, weighting 160.0 lb, was diagnosed with breast cancer
, nausea and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, altered state of consciousness, aspartate aminotransferase increased, blood alkaline phosphatase, cognitive disorder, convulsion, hypotonia, loss of consciousness, muscle rigidity. Femara dosage: 2.5 MG, QD. During the same period patient was treated with HERCEPTIN, ACTONEL, CALCIUM, CELEXA, DEXAMETHASONE, FISH OIL, LORAZEPAM. Patient recovered.Femara Side Effects Report #6123599-6
Femara side effect was reported by a Physician from JAPAN on Mar 06, 2009. Female patient, weighting 94.80 lb, was diagnosed with breast cancer
, gastric ulcer and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, cardiac failure, cardiomegaly, dyspnoea, dyspnoea exertional, gamma-glutamyltransferase increased, gingival bleeding. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ZOMETA, TAKEPRON, MUCOSTA, STRONTIUM CHLORIDE SR, ADRIACIN, CYCLOPHOSPHAMIDE, PACLITAXEL. Patient recovered.Femara Side Effects Report #5815988-1
Femara side effect was reported by a Consumer or non-health professional from SWITZERLAND on July 11, 2008. Female patient, 59 years of age, was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholestasis, gamma-glutamyltransferase increased, transaminases increased. Femara dosage: 2.5 MG/DAY. Patient recovered.
Femara Side Effects Report #5756033-6
Femara side effect was reported by a Pharmacist from GREECE on May 27, 2008. Female patient was diagnosed with hypersensitivity and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chorioretinitis, chorioretinopathy, detachment of retinal pigment epithelium, eye oedema, flushing, gamma-glutamyltransferase increased, hypercholesterolaemia. Femara dosage: unknown. During the same period patient was treated with PONSTAN, MEDROL, LIPITOR. Patient recovered.
Femara Side Effects Report #5913337-1
Femara side effect was reported by a Physician from AUSTRALIA on Sept 26, 2008. Female patient was diagnosed with thyroid disorder and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin abnormal, gamma-glutamyltransferase increased, hepatic enzyme increased, hyperthyroidism, liver disorder. Femara dosage: 2.5 MG/DAY. During the same period patient was treated with CARBIMAZOLE. Patient recovered.